Metastatic Liver Cancer: Treatment: Surgical therapy for hepatic colorectal metastases

Darren Carpizo, Yuman Fong

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The liver is the most common site for blood-borne metastasis from colorectal cancers. Until the early 1980s, it was generally accepted that hepatic metastases from colorectal cancer represented just one site in a wide systemic dissemination of tumor, and hepatectomy was rarely used as treatment. Since then, numerous studies have shown that resection can prolong survival and potentially provide cure. Surgical excision for hepatic metastases from colorectal cancer is now considered standard therapy for patients with metastases isolated to the liver. In the next section, we will summarize the data supporting such therapies, as well as clinical parameters that infl uence outcome. Since acceptance of surgery as a local therapy for this disease, a number of other local therapies have emerged as effective treatment options for hepatic metastases. The data supporting use of radiotherapy will be presented, as well as recent data documenting outcome of treatment with ablative therapies such as radiofrequency ablation and cryoablation. These tissuesparing local treatments for hepatic colorectal metastases have further extended treatment possibilities. Recent advancements in chemotherapies and biologic therapies have also contributed to effective treatment for hepatic colorectal metastases and extended the possibility for cure. As many as 5% of patients previously beyond curative therapies are being converted by systemic therapies to resectable. Those not resectable for cure are effectively treated by systemic and regional therapies to achieve extension of life. In the following sections we will present the current approach of palliative and adjuvant chemotherapy. The use of systemic and regional chemotherapy as neoadjuvant therapy prior to hepatectomy will also be discussed. The combined advances in surgery, systemic therapies, and regional ablative therapies have transformed this disease from uniformly and immediately fatal to increasingly curable.

Original languageEnglish (US)
Title of host publicationGastrointestinal Oncology
Subtitle of host publicationA Critical Multidisciplinary Team Approach
PublisherBlackwell Publishing Ltd
Pages469-480
Number of pages12
ISBN (Print)9781405127837
DOIs
StatePublished - Jan 14 2009
Externally publishedYes

Fingerprint

Liver Neoplasms
Neoplasm Metastasis
Liver
Therapeutics
Colorectal Neoplasms
Hepatectomy
Drug Therapy
Cryosurgery
Biological Therapy
Neoadjuvant Therapy
Adjuvant Chemotherapy
Life Expectancy
Radiotherapy

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Carpizo, D., & Fong, Y. (2009). Metastatic Liver Cancer: Treatment: Surgical therapy for hepatic colorectal metastases. In Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (pp. 469-480). Blackwell Publishing Ltd. https://doi.org/10.1002/9781444300147.ch20
Carpizo, Darren ; Fong, Yuman. / Metastatic Liver Cancer : Treatment: Surgical therapy for hepatic colorectal metastases. Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach. Blackwell Publishing Ltd, 2009. pp. 469-480
@inbook{39029cc44aac46daa8c554d30aed955f,
title = "Metastatic Liver Cancer: Treatment: Surgical therapy for hepatic colorectal metastases",
abstract = "The liver is the most common site for blood-borne metastasis from colorectal cancers. Until the early 1980s, it was generally accepted that hepatic metastases from colorectal cancer represented just one site in a wide systemic dissemination of tumor, and hepatectomy was rarely used as treatment. Since then, numerous studies have shown that resection can prolong survival and potentially provide cure. Surgical excision for hepatic metastases from colorectal cancer is now considered standard therapy for patients with metastases isolated to the liver. In the next section, we will summarize the data supporting such therapies, as well as clinical parameters that infl uence outcome. Since acceptance of surgery as a local therapy for this disease, a number of other local therapies have emerged as effective treatment options for hepatic metastases. The data supporting use of radiotherapy will be presented, as well as recent data documenting outcome of treatment with ablative therapies such as radiofrequency ablation and cryoablation. These tissuesparing local treatments for hepatic colorectal metastases have further extended treatment possibilities. Recent advancements in chemotherapies and biologic therapies have also contributed to effective treatment for hepatic colorectal metastases and extended the possibility for cure. As many as 5{\%} of patients previously beyond curative therapies are being converted by systemic therapies to resectable. Those not resectable for cure are effectively treated by systemic and regional therapies to achieve extension of life. In the following sections we will present the current approach of palliative and adjuvant chemotherapy. The use of systemic and regional chemotherapy as neoadjuvant therapy prior to hepatectomy will also be discussed. The combined advances in surgery, systemic therapies, and regional ablative therapies have transformed this disease from uniformly and immediately fatal to increasingly curable.",
author = "Darren Carpizo and Yuman Fong",
year = "2009",
month = "1",
day = "14",
doi = "10.1002/9781444300147.ch20",
language = "English (US)",
isbn = "9781405127837",
pages = "469--480",
booktitle = "Gastrointestinal Oncology",
publisher = "Blackwell Publishing Ltd",

}

Carpizo, D & Fong, Y 2009, Metastatic Liver Cancer: Treatment: Surgical therapy for hepatic colorectal metastases. in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach. Blackwell Publishing Ltd, pp. 469-480. https://doi.org/10.1002/9781444300147.ch20

Metastatic Liver Cancer : Treatment: Surgical therapy for hepatic colorectal metastases. / Carpizo, Darren; Fong, Yuman.

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach. Blackwell Publishing Ltd, 2009. p. 469-480.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Metastatic Liver Cancer

T2 - Treatment: Surgical therapy for hepatic colorectal metastases

AU - Carpizo, Darren

AU - Fong, Yuman

PY - 2009/1/14

Y1 - 2009/1/14

N2 - The liver is the most common site for blood-borne metastasis from colorectal cancers. Until the early 1980s, it was generally accepted that hepatic metastases from colorectal cancer represented just one site in a wide systemic dissemination of tumor, and hepatectomy was rarely used as treatment. Since then, numerous studies have shown that resection can prolong survival and potentially provide cure. Surgical excision for hepatic metastases from colorectal cancer is now considered standard therapy for patients with metastases isolated to the liver. In the next section, we will summarize the data supporting such therapies, as well as clinical parameters that infl uence outcome. Since acceptance of surgery as a local therapy for this disease, a number of other local therapies have emerged as effective treatment options for hepatic metastases. The data supporting use of radiotherapy will be presented, as well as recent data documenting outcome of treatment with ablative therapies such as radiofrequency ablation and cryoablation. These tissuesparing local treatments for hepatic colorectal metastases have further extended treatment possibilities. Recent advancements in chemotherapies and biologic therapies have also contributed to effective treatment for hepatic colorectal metastases and extended the possibility for cure. As many as 5% of patients previously beyond curative therapies are being converted by systemic therapies to resectable. Those not resectable for cure are effectively treated by systemic and regional therapies to achieve extension of life. In the following sections we will present the current approach of palliative and adjuvant chemotherapy. The use of systemic and regional chemotherapy as neoadjuvant therapy prior to hepatectomy will also be discussed. The combined advances in surgery, systemic therapies, and regional ablative therapies have transformed this disease from uniformly and immediately fatal to increasingly curable.

AB - The liver is the most common site for blood-borne metastasis from colorectal cancers. Until the early 1980s, it was generally accepted that hepatic metastases from colorectal cancer represented just one site in a wide systemic dissemination of tumor, and hepatectomy was rarely used as treatment. Since then, numerous studies have shown that resection can prolong survival and potentially provide cure. Surgical excision for hepatic metastases from colorectal cancer is now considered standard therapy for patients with metastases isolated to the liver. In the next section, we will summarize the data supporting such therapies, as well as clinical parameters that infl uence outcome. Since acceptance of surgery as a local therapy for this disease, a number of other local therapies have emerged as effective treatment options for hepatic metastases. The data supporting use of radiotherapy will be presented, as well as recent data documenting outcome of treatment with ablative therapies such as radiofrequency ablation and cryoablation. These tissuesparing local treatments for hepatic colorectal metastases have further extended treatment possibilities. Recent advancements in chemotherapies and biologic therapies have also contributed to effective treatment for hepatic colorectal metastases and extended the possibility for cure. As many as 5% of patients previously beyond curative therapies are being converted by systemic therapies to resectable. Those not resectable for cure are effectively treated by systemic and regional therapies to achieve extension of life. In the following sections we will present the current approach of palliative and adjuvant chemotherapy. The use of systemic and regional chemotherapy as neoadjuvant therapy prior to hepatectomy will also be discussed. The combined advances in surgery, systemic therapies, and regional ablative therapies have transformed this disease from uniformly and immediately fatal to increasingly curable.

UR - http://www.scopus.com/inward/record.url?scp=84890235871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890235871&partnerID=8YFLogxK

U2 - 10.1002/9781444300147.ch20

DO - 10.1002/9781444300147.ch20

M3 - Chapter

AN - SCOPUS:84890235871

SN - 9781405127837

SP - 469

EP - 480

BT - Gastrointestinal Oncology

PB - Blackwell Publishing Ltd

ER -

Carpizo D, Fong Y. Metastatic Liver Cancer: Treatment: Surgical therapy for hepatic colorectal metastases. In Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach. Blackwell Publishing Ltd. 2009. p. 469-480 https://doi.org/10.1002/9781444300147.ch20